BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5972306)

  • 1. Effects of propranolol on the circulatory changes and mobilization of free fatty acids caused by isoproterenol.
    Nakano J; Kusakari T; Berry JL
    Arch Int Pharmacodyn Ther; 1966 Nov; 164(1):120-7. PubMed ID: 5972306
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
    Bowden CR; Marchione CS
    J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
    Nishimura T; Kita S; Abiko Y
    J Pharmacol Exp Ther; 1983 Aug; 226(2):595-602. PubMed ID: 6688273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenergic beta receptors and plasma free fatty acids.
    Zsoter T; Tom H; Kraml M; Dvornik D
    J Pharmacol Exp Ther; 1966 Jun; 152(3):425-31. PubMed ID: 4380725
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenoceptors mediating metabolic responses in the greyhound.
    Kelly JG; Shanks RG
    Br J Pharmacol; 1971 Feb; 41(2):389P-390P. PubMed ID: 4396705
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of dl-propranolol on myocardial free fatty acid and carbohydrate metabolism.
    Masters TN; Glaviano VV
    J Pharmacol Exp Ther; 1969 May; 167(1):187-93. PubMed ID: 5772747
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular and metabolic effects of cyclic adenosine 3', 5'-monophosphate in unanesthetized dogs.
    Levine RA; Vogel JA
    J Pharmacol Exp Ther; 1966 Feb; 151(2):262-72. PubMed ID: 4379816
    [No Abstract]   [Full Text] [Related]  

  • 8. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
    Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
    J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
    Heer S; Femmer K
    Pharmazie; 1980; 34(5-6):317-20. PubMed ID: 6106208
    [No Abstract]   [Full Text] [Related]  

  • 10. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective metabolic and cardiovascular beta receptor antagonism in the rat.
    Stanton HC
    Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):246-58. PubMed ID: 4401080
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of dichloro-isoproterenol, pronethalol and propranolol on arterial pressure of the amyelic dog and on the rate of the enervated heart].
    Duchêne-Marullaz P; Delort P; Rispat G; Cosnier D
    C R Seances Soc Biol Fil; 1966; 160(8):1600-4. PubMed ID: 4383096
    [No Abstract]   [Full Text] [Related]  

  • 13. [Consequences of the administration of alpha or beta drenolytic agents on the mobilization of plasma free fatty acids as induced by noradrenaline and isoprenaline in the dog].
    Berlan M
    C R Seances Soc Biol Fil; 1976 Oct; 170(3):672-9. PubMed ID: 10055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic antagonism of beta adrenergic blockade in dogs. II. Hemodynamic effects of simultaneous intravenous infusion of isoproterenol and dopamine during chronic propranolol administration.
    Spotnitz HM; Avery GJ; Rose EA; Benvenisty AI; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):103-8. PubMed ID: 6243164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic profile of beta-adrenoceptor-blocking action of befunolol.
    Maruyama Y; Awaji T; Inoue M; Takeo S
    Arch Int Pharmacodyn Ther; 1991; 311():73-88. PubMed ID: 1686392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human adrenoreactive systems of different types].
    Kulinskiĭ VI; Kulinskaia IL; Chesmochakova EI
    Biull Eksp Biol Med; 1980 Oct; 90(10):395-7. PubMed ID: 7426697
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood concentrations of glucose, insulin and free fatty acids in shortly thyroxine-treated dogs: effects of alpha-blockade and isoproterenol.
    Renauld A; Sverdlik RC; Rodriguez RR
    Horm Metab Res; 1982 Feb; 14(2):101. PubMed ID: 7040189
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of changes in myocardial contractility on intramyocardial diastolic pressure].
    Cartes MF; Donoso R; Cabezas MP; Domenech RJ
    Rev Med Chil; 1981 Oct; 109(10):929-34. PubMed ID: 7344016
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of hexobendine on the content of glucose and free fatty acids in plasma under noradrenaline-infusion].
    Niessner H; Chirikdjian JJ
    Arzneimittelforschung; 1969 Jan; 19(1):62-4. PubMed ID: 5819365
    [No Abstract]   [Full Text] [Related]  

  • 20. The adrenals as a site of action for carbachol induced increases in plasma free fatty acids and glucose.
    Goldberg JM; Glaviano VV
    Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):338-44. PubMed ID: 4778623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.